Short answer
Boston Scientific (BSX) filed an 8-K current report with the SEC on May 18, 2026 reporting Item 8.01 (Other Events). $2B accelerated share repurchase with JPMorgan, funded under Boston Scientific’s $5B authorization.
Boston Scientific 8-K event analysis
AI summary of each reported item and its exhibits
Item 8.01 · Other Events
- $2B accelerated share repurchase with JPMorgan, funded under Boston Scientific’s $5B authorization
- Approximately 30.4M shares initially received, representing 80% of the repurchase price at $52.68
- Final shares determined by volume-weighted average price, less a discount, creating potential settlement variability
- Final ASR settlement expected by June 30, 2026, with $3B authorization remaining afterward
- Reduced share count may support per-share metrics, while committing $2B of capital to buybacks
Generated from the filing text and exhibits; verify against the original. What 8-K item codes mean
Other Boston Scientific 8-K filings
Get the next BSX 8-K as it lands
Follow BSX for push alerts, or ask the research agent what this filing means.